1062.895007

[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÂÀÇÀÏÐÎÑÒÀÍ ÏÎÐ. Ä/ÏÐÈÃ - ÂÎËÜÒÀÐÅÍ ÝÌÓËÜÃÅËÜ 1 % 50 Ã. Õ1

Ïðîäàâåö: ÏÓËÜÑ (Ñàíêò-Ïåòåðáóðã, (812) 108-21-58(-59), 108-20-18(-22), 103-44-38(-39))

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÂÀÇÀÏÐÎÑÒÀÍ ÏÎÐ. Ä/ÏÐÈÃ. Ð-ÐÀ Ä/ÈÍÚÅÊ. 0.02 ÌÃ ÀÌSCHWARZ PHARMA AG9149.66
ÂÀÇÅËÈÍ ÌÅÄÈÖÈÍÑÊÈÉ 25 Ã. Õ1ÒÂÅÐÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ5.84
ÂÀÇÅËÈÍ ÌÅÄÈÖÈÍÑÊÈÉ ÒÓÁÀ 30 Ã. Õ1ÔÃÓÏ ÌÓÐÎÌÑÊÈÉ ÏÐÈÁÎÐÎÑÒÐ8.79
ÂÀÇÅËÈÍÎÂÎÅ ÌÀÑËÎ ÔË. 100 ÌË. Õ1ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ17.88
ÂÀÇÅËÈÍÎÂÎÅ ÌÀÑËÎ ÔË. 25 ÌË. Õ1ÒÂÅÐÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ6.09
ÂÀÇÈËÈÏ ÒÀÁË. Ï/Î 10 ÌÃ Õ14KRKA ? ÐÓÑ168.78
ÂÀÇÈËÈÏ ÒÀÁË. Ï/Î 10 ÌÃ Õ28KRKA ? ÐÓÑ353.34
ÂÀÇÈËÈÏ ÒÀÁË. Ï/Î 20 ÌÃ Õ28KRKA ? ÐÓÑ458.52
ÂÀËÅÐÈÀÍÛ ÊÎÐÍÅÂÈÙÀ Ñ ÊÎÐÍßÌÈ Ô/Ï. 1.5 Ã. Õ20ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ31.34
ÂÀËÅÐÈÀÍÛ ÍÀÑÒÎÉÊÀ ÔË./ÈÍÄ.ÓÏ. 25 ÌË. Õ1ÀÏÒÅÊÀ ÔÀÐÌÈÊÎÍ ÎÎÎ7.19
ÂÀËÅÐÈÀÍÛ ÍÀÑÒÎÉÊÀ ÔË./ÈÍÄ.ÓÏ. 25 ÌË. Õ1ÈÂÀÍÎÂÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ7.27
ÂÀËÅÐÈÀÍÛ ÝÊÑÒÐÀÊÒ ÒÀÁË. 20 ÌÃ ÔË. Õ50ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ8.3
ÂÀËÅÐÈÀÍÛ ÝÊÑÒÐÀÊÒ ÒÀÁË. 20 ÌÃ Õ10ÄÀËÜÕÈÌÔÀÐÌ1.68
ÂÀËÈÄÎË /Ñ ÃËÞÊÎÇÎÉ/ ÒÀÁË. 60 ÌÃ Õ10ÈÐÁÈÒÑÊÈÉ ÕÈÌÈÊÎ-ÔÀÐÌÀÖÅÂ2.71
ÂÀËÈÄÎË /Ñ ÃËÞÊÎÇÎÉ/ ÒÀÁË. 60 ÌÃ Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ2.87
ÂÀËÈÄÎË ÊÀÏÑ. 50 ÌÃ Õ20ÔÀÐÌÀÃÅÍ5.69
ÂÀËÈÄÎË ÒÀÁË. 60 ÌÃ Õ10ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ3.76
ÂÀËÈÄÎË ÒÀÁË. 60 ÌÃ Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ3.75
ÂÀËÈÄÎË ÒÀÁË. 60 ÌÃ Õ6ÀËÒÀÉÂÈÒÀÌÈÍÛ2.08
ÂÀËÎÊÎÐÄÈÍ ÊÀÏËÈ ÔË. 20 ÌË. Õ1KREWEL MEUSELBACH57.47
ÂÀËÎÊÎÐÄÈÍ ÊÀÏËÈ ÔË. 50 ÌË. Õ1KREWEL MEUSELBACH129.23
ÂÀËÎÊÎÐÌÈÄ ÊÀÏËÈ ÔË./ÊÀÏ. 25 ÌË. Õ1ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ9.22
ÂÀËÒÐÅÊÑ ÒÀÁË. 500 ÌÃ Õ10GLAXOSMITHKLINE1039.39
ÂÀÐÔÀÐÈÍ ÒÀÁË. 2.5 ÌÃ Õ100NYCOMED159.48
ÂÀÐÔÀÐÈÍ ÒÀÁË. 2.5 ÌÃ Õ50NYCOMED84.45
ÂÀÒÀ ÃÈÃÈÅÍÈ×ÅÑÊÀß 100 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ12.78
ÂÀÒÀ ÃÈÃÈÅÍÈ×ÅÑÊÀß 25 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ4.98
ÂÀÒÀ ÃÈÃÈÅÍÈ×ÅÑÊÀß 250 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ33.24
ÂÀÒÀ ÃÈÃÈÅÍÈ×ÅÑÊÀß 50 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ8.29
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß 100 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ13.18
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß 25 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ5.2
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß 250 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ31.79
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß 50 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ7.56
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß ÇÈÃ-ÇÀà 50 Ã. Õ1ÌÀÑÒÅÐÈÖÀ ÇÀÎ10.8
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß ÑÒÅÐÈËÜÍÀß 100 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ17.81
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß ÑÒÅÐÈËÜÍÀß 25 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ6.72
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß ÑÒÅÐÈËÜÍÀß 250 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ40.24
ÂÀÒÀ ÕÈÐÓÐÃÈ×ÅÑÊÀß ÑÒÅÐÈËÜÍÀß 50 Ã. Õ1ÐÀÇÂÈÒÈÅ ÎÎÎ ÏÊÔ10.6
ÂÅËÀÊÑÈÍ ÒÀÁË. 37.5 ÌÃ Õ28EGIS695.46
ÂÅËÀÊÑÈÍ ÒÀÁË. 75 ÌÃ Õ28EGIS920.36
ÂÅÍÅÍ 100 Ã. (ÂÅÍÎÇÍÛÉ ÃÅËÜ) Õ1DR.THEISS NATURWAREN141.48
ÂÅÍÇÀ ÊÀÏËÈ ÔË. 20 ÌË. Õ1BITTNER RICHARD GMBH274.2
ÂÅÍÈÒÀÍ ÃÅËÜ 1 % 50 Ã. Õ1LEK(ÀÏÒÅ×ÊÀ)126.01
ÂÅÍÈÒÀÍ ÊÐÅÌ ÒÓÁÀ 50 Ã. Õ1LEK(ÀÏÒÅ×ÊÀ)128.54
ÂÅÍÒÎËÈÍ ÀÝÐÎÇ. 0.1 ÌÃ/ÄÎÇÀ 200 ÄÎÇ Õ1GLAXOSMITHKLINE123.19
ÂÅÐÀÏÀÌÈËÀ Ã/Õ Ð-Ð 0.25 % ÀÌÏ. 2 ÌË. Õ10ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ5.23
ÂÅÐÌÎÊÑ ÒÀÁË. 100 ÌÃ Õ6GEDEON RICHTER72.25
ÂÅÐÎÍÀ ÊÀÏÑ. Õ20HERBION PAKISTAN150.2
ÂÅÐÎØÏÈËÀÊÒÎÍ ÒÀÁË. 25 ÌÃ (ÑÏÈÐÎÍÎËÀÊÒÎÍ) Õ20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ.ÏÐÅÄÏÐÈßÒ44
ÂÅÐÎØÏÈÐÎÍ ÊÀÏÑ. 50 ÌÃ Õ30GEDEON RICHTER175.91
ÂÅÐÎØÏÈÐÎÍ ÒÀÁË. 25 ÌÃ Õ20GEDEON RICHTER80.54
ÂÅÑÒÈÁÎ ÒÀÁË. 16 ÌÃ Õ30ACTAVIS HS/CARDINAL HEALT264.4
ÂÅÑÒÈÁÎ ÒÀÁË. 8 ÌÃ Õ30ACTAVIS HS/CARDINAL HEALT164.27
ÂÈÀÃÐÀ ÒÀÁË. 100 ÌÃ Õ1PFIZER419.53
ÂÈÀÃÐÀ ÒÀÁË. 100 ÌÃ Õ2PFIZER768.36
ÂÈÀÃÐÀ ÒÀÁË. 100 ÌÃ Õ4PFIZER1535.17
ÂÈÀÃÐÀ ÒÀÁË. 25 ÌÃ Õ1PFIZER297.38
ÂÈÀÃÐÀ ÒÀÁË. 50 ÌÃ Õ1PFIZER339.28
ÂÈÀÃÐÀ ÒÀÁË. 50 ÌÃ Õ2PFIZER668.47
ÂÈÀÃÐÀ ÒÀÁË. 50 ÌÃ Õ4PFIZER1263.3
ÂÈÁÐÎÖÈË ÃÅËÜ ÍÀÇ. ÒÓÁÀ 12 Ã. Õ1NOVARTIS113.9
ÂÈÁÐÎÖÈË ÊÀÏËÈ ÔË./ÊÀÏ. 15 ÌË. Õ1NOVARTIS124.67
ÂÈÁÐÎÖÈË ÑÏÐÅÉ Ä/ÍÎÑÀ ÔË.ÏËÀÑÒÈÊ. Ñ ÐÀÑÏÛËÈÒÅËÅÌ 1NOVARTIS123.7
ÂÈÄÅÑÒÈÌ ÌÀÇÜ 35 Ã. Õ1ÐÅÒÈÍÎÈÄÛ164.29
ÂÈÇÈÍ ÊÀÏËÈ ÃËÀÇ. ÔË. 15 ÌË. Õ1PFIZER137.39
ÂÈÇÎÏÒÈÊ ÊÀÏËÈ ÃËÀÇ. 0.05 % ÔË./ÊÀÏ. 15 ÌË. Õ1ROMPHARM72.11
ÂÈÊÀÈÐ ÒÀÁË. Â ÁÓÌÀÃÅ Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ÒÎÌÑÊ8.61
ÂÈÊÀÑÎË ÒÀÁË. 15 ÌÃ Õ30ÁÈÎÑÈÍÒÅÇ11.38
ÂÈËÜÏÐÀÔÅÍ ÒÀÁË. Ï/Î 500 ÌÃ Õ10YAMANOUCHI SPA459.75
ÂÈÍÈËÈÍ (ÁÀËÜÇÀÌ ØÎÑÒÀÊÎÂÑÊÎÃÎ) 50 Ã. Õ1ÕÈÌÐÅÀÊÒÈÂÊÎÌÏËÅÊÒ52.17
ÂÈÍÏÎÒÐÎÏÈË ÊÀÏÑ. Õ50ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ177.32
ÂÈÍÏÎÖÅÒÈÍ ÒÀÁË. 5 ÌÃ Õ50ÀËÑÈ ÔÀÐÌÀ43.47
ÂÈÍÏÎÖÅÒÈÍ ÒÀÁË. 5 ÌÃ Õ50ÑÅÂÅÐÍÀß ÇÂÅÇÄÀ ÇÀÎ43.49
ÂÈÍÏÎÖÅÒÈÍ ÔÎÐÒÅ ÒÀÁË. 10 ÌÃ Õ30ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ60.3
ÂÈÏÐÎÑÀË Â ÌÀÇÜ 50 Ã. Õ1ÒÀËËÈÍÍÑÊÈÉ ÕÈÌÔÀÐÌÇÀÂÎÄ72.82
ÂÈÒÀ-ÈÎÄÓÐÎË ÊÀÏËÈ ÃËÀÇ. ÔË. 10 ÌË. Õ1NOVARTIS/EXCELVISION199.56
ÂÈÒÀÁÀÊÒ ÊÀÏËÈ ÃËÀÇ. 0.05 % ÔË./ÊÀÏ. 10 ÌË. Õ1NOVARTIS/EXCELVISION215.19
ÂÈÒÀÌÈÍ À 3.44 % ÔË./ÊÀÏ. 10 ÌË. (ÐÅÒÈÍÎËÀ ÀÖÅÒÀÒ)ÏÎËÈÑÈÍÒÅÇ27.96
ÂÈÒÀÌÈÍ À ÊÀÏÑ. 33000 ÌÅ (ÐÅÒÈÍÎËÀ ÀÖÅÒÀÒ) Õ10ËÞÌÈ4.75
ÂÈÒÀÌÈÍ Â1 Ð-Ð 5 % ÀÌÏ. 1 ÌË. (ÒÈÀÌÈÍÀ ÕËÎÐÈÄ) Õ10SISHUI XIERKANG PHARMACEU11.55
ÂÈÒÀÌÈÍ Â2 Ð-Ð 1 % ÀÌÏ. 1 ÌË. (ÐÈÁÎÔËÀÂÈÍ) Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ÓÔÀÂÈÒÀ39.26
ÂÈÒÀÌÈÍ Â6 Ð-Ð 5 % ÀÌÏ. 1 ÌË. (ÏÈÐÈÄÎÊÑÈÍÀ Ã/ÕË) ÕÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ10.79
ÂÈÒÀÌÈÍ Å ÊÀÏÑ. 100 ÌÃ Õ30ZENTIVA42.35
ÂÈÒÀÌÈÍ Å ÊÀÏÑ. 200 ÌÃ (ÀËÜÔÀ-ÒÎÊÎÔÅÐÎËÀ ÀÖÅÒÀÒ) ÕËÞÌÈ9.25
ÂÈÒÀÏÐÎÑÒ ÏËÞÑ ÑÂÅ×È Õ10ÍÈÆÔÀÐÌ ÎÀÎ601.34
ÂÈÒÀÏÐÎÑÒ ÑÂÅ×È Õ10ÍÈÆÔÀÐÌ ÎÀÎ429.3
ÂÈÒÀÏÐÎÑÒ ÔÎÐÒÅ ÑÂÅ×È Õ10ÍÈÆÔÀÐÌ ÎÀÎ485.19
ÂÈÒÐÓÌ ÁÜÞÒÈ ÒÀÁË. Õ30UNIPHARM INC304.34
ÂÈÒÐÓÌ ÁÜÞÒÈ ÝËÈÒ ÒÀÁË. Õ30UNIPHARM INC533.92
ÂÈÒÐÓÌ ÁÝÁÈ Õ60UNIPHARM INC328.14
ÂÈÒÐÓÌ ÂÈÆÍ ÒÀÁË. Õ60UNIPHARM INC453.72
ÂÈÒÐÓÌ ÂÈÆÍ ÔÎÐÒÅ ÒÀÁË. Õ30UNIPHARM INC360.96
ÂÈÒÐÓÌ ÊÈÄÑ ÒÀÁË. Õ30UNIPHARM INC191.93
ÂÈÒÐÓÌ ÊÈÄÑ ÒÀÁË. Õ60UNIPHARM INC299.63
ÂÈÒÐÓÌ ÎÑÒÅÎÌÀÃ ÒÀÁË. Õ30UNIPHARM INC183.96
ÂÈÒÐÓÌ ÏÅÐÔÎÌÅÍÑ ÒÀÁË. Õ30UNIPHARM INC296.73
ÂÈÒÐÓÌ ÏÐÅÍÀÒÀË ÔÎÐÒÅ ÒÀÁË. Õ100UNIPHARM INC569.35
ÂÈÒÐÓÌ ÏÐÅÍÀÒÀË ÔÎÐÒÅ ÒÀÁË. Õ30UNIPHARM INC258.07
ÂÈÒÐÓÌ ÑÓÏÅÐÑÒÐÅÑÑ ÒÀÁË. Õ30UNIPHARM INC222.57
ÂÈÒÐÓÌ ÑÓÏÅÐÑÒÐÅÑÑ ÒÀÁË. Õ60UNIPHARM INC381.48
ÂÈÒÐÓÌ ÒÀÁË. Õ100UNIPHARM INC395.37
ÂÈÒÐÓÌ ÒÀÁË. Õ60UNIPHARM INC306.15
ÂÈÒÐÓÌ ÖÅÍÒÓÐÈ ÒÀÁË. Õ30UNIPHARM INC185.28
ÂÈÒÐÓÌ ÞÍÈÎÐ ÒÀÁË. ÆÅÂ. Õ30UNIPHARM INC192.73
ÂÈÔÅÐÎÍ ÃÅËÜ 10 ÌË. Õ1ÔÅÐÎÍ142.62
ÂÈÔÅÐÎÍ ÌÀÇÜ Ä/ÍÀÐÓÆ.ÏÐÈÌ. 40000 ÌÅ 12 Ã. Õ1ÔÅÐÎÍ124.39
ÂÈÔÅÐÎÍ-1 ÑÂÅ×È ÐÅÊÒ. 150000 ÅÄ Õ10ÔÅÐÎÍ186.2
ÂÈÔÅÐÎÍ-2 ÑÂÅ×È ÐÅÊÒ. 500000 ÅÄ Õ10ÔÅÐÎÍ266.78
ÂÈÔÅÐÎÍ-3 ÑÂÅ×È ÐÅÊÒ. 1000000 ÅÄ Õ10ÔÅÐÎÍ382.41
ÂÈÔÅÐÎÍ-4 ÑÂÅ×È ÐÅÊÒ. 3000000 ÅÄ Õ10ÔÅÐÎÍ684.61
ÂÎÁÝÍÇÈÌ ÒÀÁË. Ï/Î Õ200MUCOS EMULSIONS1936.87
ÂÎÁÝÍÇÈÌ ÒÀÁË. Ï/Î Õ40MUCOS EMULSIONS535.46
ÂÎÁÝÍÇÈÌ ÒÀÁË. Ï/Î Õ800MUCOS EMULSIONS5484.25
ÂÎÄÀ ÄËß ÈÍÚÅÊÖÈÉ 2 ÌË. Õ10ÌÈÊÐÎÃÅÍ - ÀËËÅÐÃÅÍ8.33
ÂÎÄÀ ÄËß ÈÍÚÅÊÖÈÉ 5 ÌË. Õ10ÄÀËÜÕÈÌÔÀÐÌ19.25
ÂÎËÜÒÀÐÅÍ ÀÊÒÈ ÒÀÁË. 12.5 ÌÃ Õ10NOVARTIS64.85
ÂÎËÜÒÀÐÅÍ ÀÊÒÈ ÒÀÁË. 12.5 ÌÃ Õ20NOVARTIS119.7
ÂÎËÜÒÀÐÅÍ Ð-Ð 75 ÌÃ ÀÌÏ. 3 ÌË. Õ5NOVARTIS312.24
ÂÎËÜÒÀÐÅÍ ÑÂÅ×È 50 Ìà Õ10NOVARTIS PHARMA137.91
ÂÎËÜÒÀÐÅÍ ÝÌÓËÜÃÅËÜ 1 % 20 Ã. Õ1NOVARTIS99.54
ÂÎËÜÒÀÐÅÍ ÝÌÓËÜÃÅËÜ 1 % 50 Ã. Õ1NOVARTIS178.36





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru